ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 160 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $114,787,000 | -40.1% | 175,944 | 0.0% | 0.00% | – |
| Q4 2021 | $191,779,000 | -62.1% | 175,944 | -36.7% | 0.00% | – |
| Q3 2021 | $505,858,000 | -31.1% | 277,944 | 0.0% | 0.00% | – |
| Q2 2021 | $733,772,000 | -10.5% | 277,944 | +22.0% | 0.00% | – |
| Q1 2021 | $820,079,000 | +68.4% | 227,800 | +17.9% | 0.00% | – |
| Q4 2020 | $487,025,000 | 0.0% | 193,264 | 0.0% | 0.00% | – |
| Q3 2020 | $487,025,000 | -24.8% | 193,264 | -2.1% | 0.00% | – |
| Q2 2020 | $647,534,000 | +66.8% | 197,419 | +24.6% | 0.00% | – |
| Q1 2020 | $388,250,000 | -41.0% | 158,469 | +13.8% | 0.00% | – |
| Q4 2019 | $657,552,000 | +58.8% | 139,312 | +44.0% | 0.00% | – |
| Q3 2019 | $414,051,000 | -21.3% | 96,741 | +7.2% | 0.00% | – |
| Q2 2019 | $526,122,000 | +33.8% | 90,244 | -11.7% | 0.00% | – |
| Q1 2019 | $393,340,000 | +120.4% | 102,166 | +7.0% | 0.00% | – |
| Q4 2018 | $178,503,000 | -17.4% | 95,456 | +41.3% | 0.00% | – |
| Q3 2018 | $216,127,000 | +6.0% | 67,540 | 0.0% | 0.00% | – |
| Q2 2018 | $203,971,000 | -34.2% | 67,540 | -14.6% | 0.00% | – |
| Q1 2018 | $310,076,000 | +16.8% | 79,101 | +23.3% | 0.00% | – |
| Q4 2017 | $265,498,000 | -21.8% | 64,130 | +15.9% | 0.00% | – |
| Q3 2017 | $339,726,000 | +44.9% | 55,330 | +46.8% | 0.00% | – |
| Q2 2017 | $234,414,000 | -1.9% | 37,687 | 0.0% | 0.00% | – |
| Q1 2017 | $238,935,000 | +213234.8% | 37,687 | +79.6% | 0.00% | – |
| Q4 2016 | $112,000 | -64.2% | 20,987 | -62.3% | 0.00% | – |
| Q3 2016 | $313,000 | +2.6% | 55,606 | 0.0% | 0.00% | – |
| Q2 2016 | $305,000 | -41.7% | 55,606 | -21.1% | 0.00% | -100.0% |
| Q1 2016 | $523,000 | -33.2% | 70,455 | -25.3% | 0.00% | 0.0% |
| Q4 2015 | $783,000 | +64.8% | 94,327 | +79.0% | 0.00% | 0.0% |
| Q3 2015 | $475,000 | -29.4% | 52,684 | -6.0% | 0.00% | 0.0% |
| Q2 2015 | $673,000 | +46.6% | 56,060 | +31.6% | 0.00% | – |
| Q1 2015 | $459,000 | +135.4% | 42,600 | +10.9% | 0.00% | – |
| Q4 2014 | $195,000 | +93.1% | 38,400 | 0.0% | 0.00% | – |
| Q3 2014 | $101,000 | -34.8% | 38,400 | 0.0% | 0.00% | – |
| Q2 2014 | $155,000 | -11.9% | 38,400 | 0.0% | 0.00% | – |
| Q1 2014 | $176,000 | +5.4% | 38,400 | 0.0% | 0.00% | – |
| Q4 2013 | $167,000 | – | 38,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 14,013,093 | $9,142,000 | 0.78% |
| MSD Partners, L.P. | 15,151,516 | $9,885,000 | 0.54% |
| MSD Partners, L.P. | 7,575,758 | $4,942,000 | 0.27% |
| CHIRON CAPITAL MANAGEMENT, LLC | 144,960 | $95,000 | 0.06% |
| MAGNOLIA CAPITAL ADVISORS LLC | 185,456 | $121,000 | 0.05% |
| Allred Capital Management, LLC | 128,000 | $83,000 | 0.04% |
| Virtus ETF Advisers LLC | 131,413 | $86,000 | 0.04% |
| GSA CAPITAL PARTNERS LLP | 232,438 | $152,000 | 0.02% |
| ACT WEALTH MANAGEMENT, LLC | 37,071 | $24,000 | 0.01% |
| Pathway Financial Advisors LLC | 30,000 | $20,000 | 0.01% |